(Q35857235)

English

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.

scientific article published in August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

David H Moore

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

James T Kauderer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jeffrey Bell

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Linda Van Le

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

94

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

368-374

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Transvaginal sonography as a screening method for the detection of early ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Impact of age on survival of patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Treatment of ovarian cancer in elderly women. Mayo Clinic-North Central Cancer Treatment Group studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Validity of major cancer operations in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Cancer treatment and age: patient perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Determinants of cancer therapy in elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Determinants of survival in older cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Dose intensity analysis of high-dose carboplatin in refractory ovarian carcinoma relative to age

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2004.05.033

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297174%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35857235&oldid=1531854992"